PHILADELPHIA, Aug. 21 /PRNewswire-FirstCall/ -- GlaxoSmithKline
(NYSE: GSK) today announced that, beginning in February 2009, the company will
proactively report educational and charitable grants provided to US
health-related organizations. The report will be updated on a quarterly basis
and will include grants provided to various organizations including hospitals,
teaching institutions, managed care organizations, professional associations,
patient advocacy groups, and continuing medical education companies.
GSK provides grants for programs and organizations that foster increased
understanding of scientific, clinical, and healthcare issues, and contribute
to the enhancement of patient care.
'GSK sponsors a range of third-party independent educational programs to
increase awareness and knowledge about health-related issues,' said Chris
Viehbacher, President, North American Pharmaceuticals, GlaxoSmithKline. 'By
publishing information about our grants, we transparently identify the support
we offer for independent and quality education to improve the delivery of
health care for patients.'
GlaxoSmithKline -- one of the world's leading research-based
pharmaceutical and healthcare companies -- is committed to improving the
quality of human life by enabling people to do more, feel better and live
longer. For company information, visit GlaxoSmithKline on the World Wide Web
at http://us.gsk.com.
Cautionary statement regarding forward-looking statements
Under the safe harbor provisions of the U.S. Private Securities Litigation
Reform Act of 1995, GSK cautions investors that any forward-looking statements
or projections made by GSK, including those made in this announcement, are
subject to risks and uncertainties that may cause actual results to differ
materially from those projected. Factors that may affect GSK's operations are
described under 'Risk Factors' in the 'Business Review' in the company's
Annual Report on Form 20-F for 2007.
Registered in England & Wales:
No. 3888792
Registered Office:
980 Great West Road
Brentford, Middlesex
TW8 9GS
SOURCE GlaxoSmithKline
